X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (45682) 45682
Book Chapter (320) 320
Newsletter (212) 212
Book / eBook (75) 75
Magazine Article (69) 69
Newspaper Article (63) 63
Dissertation (20) 20
Publication (12) 12
Conference Proceeding (10) 10
Web Resource (8) 8
Book Review (7) 7
Reference (4) 4
Streaming Video (4) 4
Government Document (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31056) 31056
male (21949) 21949
female (16353) 16353
cardiac & cardiovascular systems (16340) 16340
animals (14117) 14117
middle aged (13264) 13264
aged (11415) 11415
ischemia (7907) 7907
myocardial infarction (7720) 7720
myocardial-infarction (7370) 7370
risk factors (7244) 7244
mortality (6710) 6710
treatment outcome (6663) 6663
cardiology (6662) 6662
heart attacks (6536) 6536
acute myocardial-infarction (5933) 5933
heart (5778) 5778
rats (5629) 5629
cardiovascular disease (5189) 5189
pharmacology & pharmacy (5093) 5093
myocardial infarction - drug therapy (5041) 5041
adult (4905) 4905
time factors (4574) 4574
care and treatment (4563) 4563
cardiovascular (4312) 4312
heart attack (4228) 4228
myocardial ischemia - drug therapy (4174) 4174
heart failure (4138) 4138
electrocardiography (4131) 4131
medicine & public health (4070) 4070
cardiac patients (3686) 3686
peripheral vascular disease (3685) 3685
cardiovascular diseases (3574) 3574
prognosis (3505) 3505
abridged index medicus (3480) 3480
analysis (3468) 3468
myocardial ischemia (3465) 3465
coronary heart disease (3442) 3442
research (3354) 3354
heart diseases (3304) 3304
percutaneous coronary intervention (3265) 3265
reperfusion (3143) 3143
health aspects (3100) 3100
prospective studies (3094) 3094
myocardial infarction - physiopathology (3077) 3077
medicine, general & internal (3042) 3042
disease models, animal (3021) 3021
drug therapy (2940) 2940
coronary vessels (2929) 2929
myocardial infarction - therapy (2920) 2920
therapy (2894) 2894
follow-up studies (2868) 2868
risk (2830) 2830
coronary artery disease (2750) 2750
myocardium - metabolism (2709) 2709
acute coronary syndromes (2677) 2677
infarction (2615) 2615
apoptosis (2591) 2591
coronary angiography (2584) 2584
aged, 80 and over (2581) 2581
patients (2511) 2511
myocardial ischemia - physiopathology (2498) 2498
surgery (2485) 2485
myocardium - pathology (2475) 2475
diabetes (2469) 2469
rats, sprague-dawley (2442) 2442
angioplasty (2429) 2429
stroke (2378) 2378
oxidative stress (2377) 2377
myocardial infarction - pathology (2369) 2369
studies (2368) 2368
medicine, research & experimental (2320) 2320
disease (2310) 2310
mice (2285) 2285
atherosclerosis (2280) 2280
inflammation (2262) 2262
cell biology (2234) 2234
hypertension (2231) 2231
stents (2211) 2211
risk assessment (2187) 2187
retrospective studies (2165) 2165
medicine (2155) 2155
heart-failure (2153) 2153
physiology (2108) 2108
internal medicine (2023) 2023
platelet aggregation inhibitors - therapeutic use (2016) 2016
myocardial infarction - mortality (1997) 1997
medical research (1975) 1975
reperfusion injury (1960) 1960
rodents (1945) 1945
coronary-artery-disease (1916) 1916
prevention (1912) 1912
myocardial reperfusion injury - drug therapy (1881) 1881
echocardiography (1854) 1854
clinical trials (1822) 1822
physiological aspects (1783) 1783
myocardial infarction - complications (1757) 1757
heart - drug effects (1735) 1735
thrombosis (1727) 1727
rats, wistar (1712) 1712
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (42) 42
Online Resources - Online (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Baycrest Hospital - Wellness Library (1) 1
Bridgepoint Health - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Providence Healthcare - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (44896) 44896
Russian (824) 824
German (322) 322
Japanese (271) 271
Spanish (220) 220
Chinese (212) 212
French (198) 198
Italian (157) 157
Portuguese (97) 97
Polish (90) 90
Ukrainian (37) 37
Czech (32) 32
Danish (31) 31
Hungarian (25) 25
Norwegian (21) 21
Dutch (11) 11
Romanian (10) 10
Swedish (10) 10
Turkish (10) 10
Lithuanian (8) 8
Serbian (5) 5
Slovak (5) 5
Hebrew (4) 4
Croatian (3) 3
Korean (3) 3
Finnish (2) 2
Arabic (1) 1
Bosnian (1) 1
Bulgarian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 2013, Volume 62, Issue 24, pp. 2261 - 2273
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 03/2008, Volume 117, Issue 10, pp. 1283 - 1291
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2010, Volume 55, Issue 25, pp. 2825 - 2832
Journal Article
Cellular and molecular life sciences : CMLS, ISSN 1420-682X, 08/2017, Volume 74, Issue 15, pp. 2795 - 2813
.... Therefore, cyclophilin D is an attractive target for pharmacological or genetic therapies to reduce ischemia-reperfusion injury in various animal models and humans... 
Oxidative stress | Cyclophilin D | Ischemia–reperfusion injury | Cardioprotection | Mitochondrial permeability transition pores | BIOCHEMISTRY & MOLECULAR BIOLOGY | ADP/ATP CARRIER | PHOSPHATE CARRIER | CELL-DEATH | CELL BIOLOGY | Ischemia-reperfusion injury | CYCLOSPORINE-A | MYOCARDIAL INFARCT SIZE | ATP SYNTHASE | NITRIC-OXIDE | CA2+ UPTAKE | ADENINE-NUCLEOTIDE TRANSLOCASE | Myocardial Ischemia - metabolism | Mitochondrial Membrane Transport Proteins - metabolism | Mitochondrial Membrane Transport Proteins - antagonists & inhibitors | Calcium - metabolism | Protein Interaction Maps - drug effects | Humans | Cyclophilins - metabolism | Cardiotonic Agents - pharmacology | Molecular Targeted Therapy | Drug Discovery | Myocardial Ischemia - drug therapy | Cyclophilins - antagonists & inhibitors | Myocardial Reperfusion Injury - metabolism | Animals | Protein Processing, Post-Translational - drug effects | Myocardium - metabolism | Heart - drug effects | Myocardial Reperfusion Injury - drug therapy | Oxidative Stress - drug effects | Energy Metabolism - drug effects | Medical colleges | Medical research | Ischemia | Analysis | Cardiac patients | Medicine, Experimental | Permeability | Heart | Myocardial infarction | Animal models | Mitochondrial permeability transition pore | Cyclosporins | Pathogenesis | Membrane permeability | Mitochondrial DNA | Information dissemination | Reperfusion | Bioenergetics | Attenuation | Physiology | Inhibition | Damage | Cardiology | Heart diseases | Pharmacology | Metabolism | Patients | Injury prevention | Inhibitors | Myocardium | Infarction
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 23, pp. 2155 - 2166
Patients who had received a drug-eluting stent and then dual antiplatelet therapy for 12 months were randomly assigned to 18 more months of therapy or aspirin alone... 
TRIALS | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | MULTICENTER | CLOPIDOGREL | TICAGRELOR | THROMBOSIS | RATIONALE | PREVENTION | ASPIRIN | CLINICAL-OUTCOMES | Piperazines - administration & dosage | Prasugrel Hydrochloride | Thiophenes - adverse effects | Humans | Middle Aged | Male | Thiophenes - administration & dosage | Aspirin - administration & dosage | Incidence | Time Factors | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Myocardial Ischemia - mortality | Thrombosis - prevention & control | Drug Therapy, Combination | Myocardial Ischemia - epidemiology | Platelet Aggregation Inhibitors - adverse effects | Drug-Eluting Stents | Drug Administration Schedule | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Myocardial Ischemia - therapy | Aged | Hemorrhage - chemically induced | Aggregation | Treatment outcome | Care and treatment | Usage | Blood platelets | Analysis | Drug-eluting stents | Dosage and administration | Cardiovascular diseases | Thrombosis | Health aspects | Blood clot | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Drug delivery | Patients | Bleeding | Clinical outcomes | Cerebrovascular system | Coronary vessels | Implants | Clopidogrel | Drug therapy | Stents
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 2010, Volume 122, Issue 1, pp. 11 - 19
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 379, Issue 3, pp. 215 - 225
BACKGROUND Combination antiplatelet therapy with clopidogrel and aspirin may reduce the rate of recurrent stroke during the first 3 months after a minor ischemic stroke or transient ischemic attack (TIA... 
TRIAL | MEDICINE, GENERAL & INTERNAL | EFFICACY | TICAGRELOR | SAFETY | MINOR STROKE | ATTACK | Stroke - prevention & control | Ischemic Attack, Transient - drug therapy | Double-Blind Method | Humans | Middle Aged | Male | Risk | Brain Ischemia - prevention & control | Secondary Prevention | Stroke - drug therapy | Ischemia - mortality | Ticlopidine - analogs & derivatives | Aspirin - administration & dosage | Drug Therapy, Combination - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Clopidogrel | Female | Aged | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Platelet Aggregation Inhibitors - adverse effects | Stroke (Disease) | Cerebral ischemia | Safety and security measures | Dosage and administration | Drug therapy | Stroke patients | Health aspects | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Nuclear magnetic resonance--NMR | Medical imaging | Transient ischemic attack | Hemorrhage | Neurological diseases | Ischemia | Blood platelets | Tomography | Blood pressure | Diabetes | Drug dosages | Neurological disorders | Brain Ischemia | Ischemic Attack | administration & dosage | Combination | Transient | Neurologi | chemically induced | Drug Therapy | prevention & control | Ticlopidine | Neurology | Myocardial Infarction | analogs & derivatives | Platelet Aggregation Inhibitors | adverse effects | mortality
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2008, Volume 359, Issue 12, pp. 1238 - 1251
.... The results will help guide therapy for secondary stroke prevention. Aspirin plus extended-release dipyridamole was found to have an efficacy similar to that of clopidogrel in the prevention of recurrent stroke... 
ACTIVE CONTROLLED-TRIALS | HIGH-RISK PATIENTS | TICLOPIDINE | TRANSIENT ISCHEMIC ATTACK | DOUBLE-BLIND | PREVENTION | RANDOMIZED CONTROLLED-TRIAL | ARTERIAL ORIGIN ESPRIT | CEREBRAL-ISCHEMIA | UMCG Approved | NON-INFERIORITY TRIALS | ISSUES | MEDICINE, GENERAL & INTERNAL | PLACEBO | DESIGN | WARFARIN | REGIMENS | Myocardial Infarction - epidemiology | Benzoates - therapeutic use | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Risk | Secondary Prevention | Aspirin - administration & dosage | Vascular Diseases - mortality | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Dipyridamole - adverse effects | Female | Stroke - epidemiology | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Dipyridamole - therapeutic use | Benzimidazoles - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Brain Ischemia - epidemiology | Stroke - prevention & control | Double-Blind Method | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Ischemia - prevention & control | Factor Analysis, Statistical | Stroke - drug therapy | Ticlopidine - analogs & derivatives | Aged | Hemorrhage - chemically induced | Delayed-Action Preparations | Stroke (Disease) | Aspirin | Usage | Care and treatment | Dipyridamole | Clopidogrel | Health aspects | Stroke | Index Medicus | Abridged Index Medicus | Recurrence | Brain Ischemia | Benzimidazoles | Follow-Up Studies | Neurons and Cognition | Cognition | Hemorrhage | Drug Delivery Systems | Life Sciences | Angiotensin II Type 1 Receptor Blockers | Angiotensin-Converting Enzyme Inhibitors | Vascular Diseases | Mental Status Schedule | Retrospective Studies | Severity of Illness Index | Disability Evaluation | Benzoates | Drug Administration Schedule | International Cooperation | Ticlopidine | Myocardial Infarction | Platelet Aggregation Inhibitors | Santé publique et épidémiologie | Original | Dipyridamole/adverse effects/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Recurrence/prevention & control | Benzoates/therapeutic use | Brain Ischemia/epidemiology/prevention & control | MEDICIN OCH HÄLSOVETENSKAP | Platelet Aggregation Inhibitors/administration & dosage/adverse | Combination | MEDICAL AND HEALTH SCIENCES | Aspirin/administration & dosage/adverse effects | Myocardial Infarction/epidemiology | Factor Analysis | Benzimidazoles/therapeutic use | Drug Therapy | Ticlopidine/adverse effects/analogs & derivatives/therapeutic use | effects/therapeutic use | Vascular Diseases/mortality | Hemorrhage/chemically induced | Stroke/drug therapy/epidemiology/prevention & control | Statistical | Kaplan-Meiers Estimate
Journal Article